Sitagliptin/Pioglitazone Combo Application Withdrawn in EU

Nov 25, 2011
1,526 views

Sitagliptin/Pioglitazone Combo Application Withdrawn in EU

Merck Sharp & Dohme Inc. has withdrawn its marketing authorization application for sitagliptin/pioglitazone (Janacti).